| EPIGENE.COM Epigenesis Pharmaceuticals, LLC
78935316 21 Jul 2006 | on 17 Jan 2011 | medical diagnostic and therapeutic preparations, all for administratio... Class 005 Class 005 Pharmaceutical Products medical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasconconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ards), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (svt), adenosine stress tests, infantile respiratory distress syndrome (infantile rds), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (copd), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostate | | | EPIGENESIS Epigenesis Pharmaceuticals, LLC
78790746 12 Jan 2006 | on 11 Jan 2010 | medical diagnostic and therapeutic preparations, all for administratio... Class 005 Class 005 Pharmaceutical Products EPI GENESIS | | | EPIGENESIS PHARMACEUTICALS Epigenesis Pharmaceuticals, LLC
78790767 12 Jan 2006 | on 11 Jan 2010 | medical diagnostic and therapeutic preparations, all for administratio... Class 005 Class 005 Pharmaceutical Products medical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasconconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (SVT), adenosine stress tests, infantile respiratory distress syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostate | | | EE EPIGENESIS PHARMACEUTICALS LLC
78355965 22 Jan 2004 | on 10 Aug 2009 | Medical diagnostic and therapeutic preparations for clinical use, all ... Class 005 Class 005 Pharmaceutical Products The mark consists of stylized letter "E" connected to another transposed stylized letter "E" in a top to bottom alignment. | | | HALZYME Halzyme Technologies, Inc.
78748905 07 Nov 2005 | on 11 May 2009 | biotechnology consultation services,consultation in the field of gener... Class 039 Class 039 Transportation & Storage Services biotechnology consultation services Class 042 Class 042 Computer & Software Services & Scientific Services consultation in the field of general aviation | | | HALZYME Halzyme Technologies, Inc.
78836493 14 Mar 2006 | on 06 Feb 2009 | pharmaceuticals for the treatment of thrombolytic diseases, heart dise... Class 001 Class 001 Chemical Products pharmaceuticals for the treatment of thrombolytic diseases, heart diseases and vascular disorders Class 005 Class 005 Pharmaceutical Products HAL ENZYME | | | EPIGENESIS PHARMACEUTICALS EPIGENESIS PHARMACEUTICALS LLC
78355970 22 Jan 2004 | on 27 Oct 2008 | Medical diagnostic and therapeutic preparations, all for administratio... Class 005 Class 005 Pharmaceutical Products PHARMACEUTICALS | | | EPIGENESIS.COM EPIGENESIS PHARMACEUTICALS LLC
76122100 23 Aug 2000 | on 14 Jul 2006 | Medical diagnostic and therapeutic preparations and devices, for admin... Class 005 Class 005 Pharmaceutical Products Medical diagnostic and therapeutic preparations and devices, for administering same, sold filled, with, diagnostic and therapeutic preparations, all for administration via diverse routes of administration, including through the respiratory airways, and medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms, pharmaceutical preparations for testing and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as all metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostrate included | | | EPIGENESISPHARMACEUTICALS.COM EPIGENESIS PHARMACEUTICALS LLC
76360212 07 Jan 2002 | on 02 Jul 2006 | medical diagnostic and therapeutic preparations and devices for admini... Class 005 Class 005 Pharmaceutical Products medical diagnostic and therapeutic preparations and devices for administering same, sold filled with diagnostic and therapeutic preparations or separately as a kit, all for administration via diverse routes of administration, including through the respiratory airways, and medical devices for administering the pharmaceuticals, sold filled or separately as a kit, the preparations including polynucleotides, proteins and/or organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms,; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, e.g., colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc., as well as all metastatic cancers, e.g.; cancers which metastasized to the lung(s), breast, liver and prostate included | | | HALZYME Halzyme Technologies, Inc.
76348916 14 Dec 2001 | on 12 Mar 2006 | PHARMACEUTICALS FOR THE TREATMENT OF THROMBOLYTIC DISEASES, HEART DISE... Class 001 Class 001 Chemical Products PHARMACEUTICALS FOR THE TREATMENT OF THROMBOLYTIC DISEASES, HEART DISEASES AND VASCULAR DISORDERS Class 005 Class 005 Pharmaceutical Products PHARMACEUTICALS FOR THE TREATMENT OF THROMBOLYTIC DISEASES, HEART DISEASES AND VASCULAR DISORDERS | |